Pyxis Oncology Inc
(PYXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,557 | -3,256 | -73,790 | -58,193 | -35,144 |
| Depreciation Amortization | -1,223 | -172 | -2,861 | -2,110 | -1,153 |
| Accounts receivable | N/A | -8,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,812 | -1,365 | -3,507 | -3,857 | -2,313 |
| Other Working Capital | -9,463 | -21,766 | -11,664 | -9,356 | -10,446 |
| Other Operating Activity | 5,714 | 13,849 | 21,113 | 18,061 | 11,184 |
| Operating Cash Flow | $-23,717 | $-20,710 | $-70,709 | $-55,455 | $-37,872 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,257 | -18,261 | -104,783 | -115,010 | -114,983 |
| PPE Investments | -237 | -237 | -6,726 | -6,726 | -6,665 |
| Net Acquisitions | N/A | N/A | 6,660 | 6,659 | N/A |
| Investing Cash Flow | $-18,494 | $-18,498 | $-104,849 | $-115,077 | $-121,648 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 57,860 | 57,707 | 6,374 | 6,347 | 6,125 |
| Other Financing Activity | -239 | -196 | -445 | -393 | 0 |
| Financing Cash Flow | $57,621 | $57,511 | $5,929 | $5,954 | $6,125 |
| Beginning Cash Position | 11,136 | 11,136 | 180,765 | 180,765 | 180,765 |
| End Cash Position | 26,546 | 29,439 | 11,136 | 16,187 | 27,370 |
| Net Cash Flow | $15,410 | $18,303 | $-169,629 | $-164,578 | $-153,395 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,717 | -20,710 | -70,709 | -55,455 | -37,872 |
| Capital Expenditure | -237 | -237 | -6,726 | -6,726 | -6,665 |
| Free Cash Flow | -23,954 | -20,947 | -77,435 | -62,181 | -44,537 |